Can Natalizumab cure relapsing-remitting multiple sclerosis?

Question

Hello doctor,

I'm 60 years old and have been living with multiple sclerosis for the past six years. I recently read about a new drug called Tyruko that some are calling a breakthrough. There's talk that it might even cure MS. I'm currently taking Tecfidera, but I still struggle with fatigue and muscle weakness on bad days.

Should I consider switching to Tyruko? Could it actually cure my MS? A friend of my neighbor just started it and says she's feeling much better. I'm open to trying anything that might help. What's your opinion on Tyruko compared to Tecfidera? Please help.

Thank you.

Answer 1

Hello,

Welcome to icliniq.com.

I can understand your concern.

Natalizumab is indicated as a single disease-modifying therapy in adults with highly active relapsing-remitting multiple sclerosis for the following patient groups:

Tyruko (Natalizumab) may be considered for people with highly active multiple sclerosis (MS) who continue to have disease activity despite completing a full course of at least one disease-modifying therapy (DMT). It's also an option for those with rapidly worsening relapsing-remitting MS, especially if they've had two or more disabling relapses within a year and show one or more active lesions on brain MRI (with Gadolinium enhancement) or a noticeable increase in T2 lesion load compared to a recent MRI. It's important to know that, as of now, there is no cure for MS.

Choosing whether to switch medications, like from Tecfidera (Natalizumab) to Tyruko, should be a shared decision between you and your neurologist. Your doctor will consider many factors, including your symptoms, clinical condition, MRI findings, lab results, and overall health.

I hope this helps.

Kindly follow up if you have more concerns.

Thank you.